RT Book, Section
A1 Kiefer, Todd
A1 Granger, Christopher B.
A1 Jackson, Kevin P.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193147224
T1 Coronary Heart Disease (Atherosclerotic CAD, Ischemic Heart Disease)
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193147224
RD 2024/10/07
AB Key  Clinical  Updates  in  Coronary  Heart  Disease  (Atherosclerotic  CAD,  Ischemic  Heart  Disease)The  USPSTF  issued  new  guidance  on  the  use  of  aspirin  for  primary  prevention  of  cardiovascular  events;  patients  aged  40–49  years  should  have  a  shared  decision-making  conversation  regarding  the  potential  risks  and  benefits  of  initiating  aspirin  therapy  for  primary  prevention,  and  patients  aged  60  years  or  older  should  not  initiate  aspirin  for  primary  prevention  of  CVD.U.S.  Preventive  Services  Task  Force.